image
Molecular Partners AG MOLN
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 5.33
0.947 %
$ 223 M
Market Cap
-2.49
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -96.29% -52.59% -52.40%
Annual Report FY 10-K 2022-12-31 1931.68% 284.77% 283.88%
Annual Report FY 10-K 2021-12-31 -0.15% -1.63% -8.73%
Annual Report FY 10-K 2020-12-31 -54.16% -72.96% -59.10%
Annual Report FY 10-K 2019-12-31 96.84% 2.02% 2.00%
Annual Report FY 10-K 2018-12-31 -48.27% -45.64% -44.75%
Annual Report FY 10-K 2017-12-31 -13.12% -36.63% -32.63%
Annual Report FY 10-K 2016-12-31 -20.88% -12406.13% -778.50%
Annual Report FY 10-K 2015-12-31 9.37% 93.48% -120.50%
Annual Report FY 10-K 2014-12-31 -17.87% -31.96% -74.13%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -73.20% -43.40% -8.15%
Quarterly Report Q2 8-K 2024-06-30 273.73% 5.66% -0.59%
Quarterly Report Q1 8-K 2024-03-31 -10.23% 26.09% -5.10%
Quarterly Report Q4 8-K 2023-12-31 -61.68% 0.63% -11.32%
Quarterly Report Q3 8-K 2023-09-30 8.73% 4.29% 8.19%
Quarterly Report Q2 8-K 2023-06-30 -96.47% -499.66% -152.35%
Quarterly Report Q1 8-K 2023-03-31 -98.23% -10.01% -9.89%
Quarterly Report Q4 8-K 2022-12-31 51.72% -11.15% 5.28%
Quarterly Report Q3 8-K 2022-09-30 -33.74% 2.90% -14.45%
Quarterly Report Q2 8-K 2022-06-30 265.64% 84.33% 61.30%
Quarterly Report Q1 8-K 2022-03-31 21099.75% 1025.02% 923.28%
Quarterly Report Q4 8-K 2021-12-31 14.89% 16.96% 21.31%
Quarterly Report Q3 8-K 2021-09-30 1146.29% 25.17% 15.38%
Quarterly Report Q2 8-K 2021-06-30 -13.42% -49.20% -49.59%
Quarterly Report Q1 8-K 2021-03-31 -78.58% -24.05% -51.64%
Quarterly Report Q4 8-K 2020-12-31 -54.77% -83.21% -65.41%
Quarterly Report Q3 8-K 2020-09-30 -91.72% -39.73% -25.08%
Quarterly Report Q2 8-K 2020-06-30 -45.23% -78.95% -75.34%
Quarterly Report Q1 8-K 2020-03-31 -43.84% -109.43% -97.08%
Quarterly Report Q4 8-K 2019-12-31 646.67% 7.00% 1.92%
Quarterly Report Q3 8-K 2019-09-30 646.67% 7.00% 1.92%
Quarterly Report Q2 8-K 2019-06-30 43.55% -8.74% 2.17%
Quarterly Report Q1 8-K 2019-03-31 43.55% -8.74% 2.17%
Quarterly Report Q4 8-K 2018-12-31 -93.47% -318.24% -171.38%
Quarterly Report Q3 8-K 2018-09-30 -93.47% -318.24% -171.38%
Quarterly Report Q2 8-K 2018-06-30 62.09% 50.24% 36.81%
Quarterly Report Q1 8-K 2018-03-31 52.26% 22.89% 5.40%
Quarterly Report Q4 8-K 2017-12-31 82.34% 20.61% 28.64%
Quarterly Report Q3 8-K 2017-09-30 22.84% 40.66% 0.93%
Quarterly Report Q2 8-K 2017-06-30 -56.81% -112.89% -58.78%
Quarterly Report Q1 8-K 2017-03-31 -54.41% -80.95% -204.55%
Quarterly Report Q4 8-K 2016-12-31 -52.11% -282.16% -1132.82%
Quarterly Report Q3 8-K 2016-09-30 -42.42% -92.73% -209.09%
Quarterly Report Q2 8-K 2016-06-30 23.75% -18.87% -79.40%
Quarterly Report Q1 8-K 2016-03-31 17.24% -75.00% -450.00%
Quarterly Report Q4 8-K 2015-12-31 19.24% 127.67% -12.79%
Quarterly Report Q3 8-K 2015-09-30 47.76% 400.00% 175.00%
Quarterly Report Q2 8-K 2015-06-30 -17.69% -613.23% -469.75%
Quarterly Report Q1 8-K 2015-03-31 -12.37% -316.26% -53.36%
Quarterly Report Q4 8-K 2014-12-31 -17.02% -273.49% -25.72%
Quarterly Report Q3 8-K 2014-09-30 -17.33% -38.39% -55.19%
Quarterly Report Q2 8-K 2014-06-30 -18.33% -57.49% -58.02%
Quarterly Report Q1 8-K 2014-03-31 -18.33% -57.49% -58.02%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%